Ironwood Pharmaceuticals IRWD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's accounts payable?
- Ironwood Pharmaceuticals (IRWD) reported accounts payable of $3.24M in Q1 2026.
- How has Ironwood Pharmaceuticals's accounts payable changed year-over-year?
- Ironwood Pharmaceuticals's accounts payable decreased by 44.4% year-over-year, from $5.83M to $3.24M.
- What is the long-term trend for Ironwood Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's accounts payable has grown at a 34.4% compound annual growth rate (CAGR), from $661K to $2.9M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.